Blog
Revolutionary Automated CAR-T Manufacturing: High Efficiency Lower Costs
π° A French company is developing an automated system for manufacturing CAR-T cells at scale, reducing costs. ππ‘π¬ππ°π©βπ¬π
Revolutionizing Bioprocessing with IoT Innovation
ππ‘ The IoT can revolutionize bioprocessing by connecting devices and exchanging data, leading to more efficient experiments and automation. π
Revolutionary Partnership to Enhance mRNA Therapeutics
π’ Lonza and Oxford Nanopore collaborate to advance mRNA Therapeutics! This partnership aims to improve mRNA product analysis π₯π§¬π
German Biopharmaceutical Supplier Targets Korea’s Booming Biomanufacturing Market
π° Sartorius, a German supplier, targets Korea's biomanufacturing market π©πͺππ°π·. Plans to establish sales and production center ππ. Expanding presence in Asian market ππ₯.
Lonza’s Upcoming Approvals Will Revolutionize CGT Biz in 2024
πΌLonza is looking to strengthen its cell and gene therapy business through upcoming approvals in 2024. ππ¬ππͺπππΌπ
Revolutionizing Bioprocesses with Machine Learning
π’ Machine learning (ML) could revolutionize biopharmaceutical processes by creating predictive models. π¬ Manufacturers need high-density process sensors to train ML algorithms. π« Sensors should be noninvasive and prevent contamination. 𧫠Researchers have developed a noninvasive CO2 sensor for cell culture monitoring. π‘ Machine learning can still be applied even with limited real-time data. π A machine learning-based method for protein quality assessment using limited data has been developed. πͺ ML has the power to simplify process monitoring and improve bioprocess outcomes.
Resilience Teams Up with VGXI for pDNA Supply
Resilience π’ selects VGXI π€ for pDNA supply, fostering promising partnership in the π§ͺ biotech industry. Resilience VGXI biotech
Revolutionary Packaging Method Cuts Costs & Risks in Lentiviral Manufacturing
π Dive into the world of lentiviral manufacturing with the LV Edge Packaging! π°π Reduce costs and risks for better therapies! πβ¨
Revolutionary Cystic Fibrosis Treatment Secures Β£26m Funding
π’ Exciting news! Enterprise Therapeutics Ltd has raised Β£26m for a groundbreaking cystic fibrosis drug trial. πΌπ€π¨ββοΈ
Alcami Boosts Storage Services with Pacific Pharma Acquisition!
π’ Alcami acquires Pacific Pharma Group, boosting storage services. πΌ Expansion in pharmaceutical storage, logistics, and temperature-controlled distribution. π‘οΈ Strengthening global biotech presence. πͺπ
